References
Marcantonio ER (2017) Delirium in hospitalized older adults. N Engl J Med 377(15):1456–1466
Devlin JW et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46(9):e825–e873
Morandi A et al (2017) Worldwide survey of the “assessing pain, both spontaneous awakening and breathing trials, choice of drugs, delirium monitoring/management, early exercise/mobility, and family empowerment” (ABCDEF) Bundle. Crit Care Med 45(11):e1111–e1122
Collet MO et al (2018) Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med 44(7):1081–1089
Dudley DL, Rowlett DB, Loebel PJ (1979) Emergency use of intravenous haloperidol. Gen Hosp Psychiatry 1(3):240–246
Girard TD et al (2018) Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 379(26):2506–2516
Andersen-Ranberg NC et al (2022) Haloperidol for the treatment of delirium in ICU patients. N Engl J Med 379:2506
Ely E et al (2001) Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (cam-icu). JAMA 286(21):2703–2710
Bergeron N et al (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27(5):859–864
Andersen-Ranberg NC et al (2023) Haloperidol. vs placebo for the treatment of delirium in ICU patients: a pre-planned, secondary Bayesian analysis of the AID–ICU trial. Intensive Care Med 49(4):441
Andersen-Ranberg NC et al (2023) Haloperidol for the treatment of delirium in critically ill patients: an updated systematic review with meta-analysis and trial sequential analysis. Crit Care 27(1):329
Tomichek JE et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20(1):378
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
NCAN: coordinating investigator of the AID-ICU trial, part of the trial steering committee. TDG: investigator and steering committee member for the MIND-USA Study. AP: initiator and grant holder of the AID-ICU trial, part of the trial steering committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Andersen-Ranberg, N.C., Girard, T.D. & Perner, A. Haloperidol and delirium: what is next?. Intensive Care Med 49, 1535–1537 (2023). https://doi.org/10.1007/s00134-023-07232-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-023-07232-3